期刊文献+

紫茜胶囊对慢性原发性血小板减少性紫癜患者IL-2、sIL-2R的影响 被引量:2

The Effect on IL-2 and sIL-2R of chronic Idiopathic Thrombocytopenic Purpura treated by Zi Qian capsule
下载PDF
导出
摘要 目的:探讨紫茜胶囊对慢性原发性血小板减少性紫癜(CIIP)患者血清IL-2及sIL-2R的影响及作用机理。方法:将64例CITP患者分为紫茜胶囊治疗组和升血小板胶囊对照组各32例,用ELISA方法检测CITP患者治疗前后血清IL-2、sIL-2R的含量变化。结果:CITP患者的IL-2水平明显低于正常对照组,sIL-2R则高于正常对照组,二者经治疗后均有明显改善,但治疗组优于对照组。结论:血清IL-2及sIL-2R水平变化与CITP的发病有关,紫茜胶囊可通过降低IL-2、升高sIL-2R改善CITP患者的细胞免疫功能。 Objective: To explore Interleukin - 2 (IL - 2)and Soluble Inter-leukin - 2 Receptorin(sIL- 2R) expression in chronic Idiopathic Thrombo-cytopenic Purpura (CITP) patients and the effect on it treated by Zi Qian capsule, and study the possible mechanism. Methods: 64 cases with CITP were randomly divided into two groups. The control group was treated with promote thrombocyte capsule, while the treated group was treated with Zi Qian capsule. Examine the variety of serum IL - 2 and sIL - 2R before and after therapy using the ELISA method. Results: The level of IL - 2 of CITP was obviously lower than normal control group, while sIL - 2R higher than normal control group. Two groups both have obvious improvement through treatment, but treated group was superior to control group. Conclusion: The generation of CITP was related to level change of serum IL - 2 and sIL-2R. The Zi Qian capsule can possibly adjust the CITP patient's cellular immunity function through reducing the serum level of IL - 2 and raising the level of serum sIL-2R.
作者 孙凤 朱云丽
出处 《中医药信息》 2007年第2期62-62,F0003,共2页 Information on Traditional Chinese Medicine
基金 黑龙江省科技攻关项目(20020101193)
关键词 血小板减少性紫癜 原发性 紫茜胶囊 IL-2及SIL-2R idiopathic Thrombocytopenic Purpura Zi Qian capsule IL-2 sIL-2R Experimental study
  • 相关文献

参考文献4

二级参考文献16

  • 1Bussel JB. Novel approaches to refractory immune thrombocytopenicpurpura[J] .Blood Rev, 2002,16(11) :31 - 36.
  • 2Araki K, Harada K, Nakamoto K, et al. Clinical significance of serum soluble IL-2R levels in patients with adult T cell leukaemia(ATL) and HTLV- 1 carriers[J]. Clin Exp Immunol,2000,119(2) :259 - 263.
  • 3Wang JC, Wang A. Plasma soluble interleukin-2 receptor in patients with primary myelofibrosis[J]. Br J Haematol, 1994, 86(4):380 -382.
  • 4Webber NP, Mascarenhas JO, Crow NK, et al. Functional properties of lymphocytes in Idiopathic Thrombocytopenic Purpura[J]. Hum Imrmmol, 2001,62(12): 1345 - 1355.
  • 5宋理君,中华内科杂志,1989年,28卷,364页
  • 6丁桂凤,上海免疫学杂志,1988年,8卷,64页
  • 7Wang JC, Wang A. Plasma soluble interleukin-2 receptor in patientswith primary myelofibrosis. Br J Haernatol, 1994; 86: 380 - 382
  • 8Cimino G, Amadori S, Cava MC, et al. Serum interleukin-2 ( IL-2), soluble interleulkin-2 receptor and tumor necrosis factor α levels are significantly increased in acute myeloid leukemia patients. Leukemia, 1991; 5: 32 - 35
  • 9Zwierzina H, Herold M, Schollenberger S, et al. Detection of solu ble IL-2 receptor in the serum of patients with myelodysplastic syndrome: induction under therapy with GM-CSF. Br J Haematol,1991; 79: 438 - 443
  • 10Ward MM, Dooley MA, Christenson VD, et al. The relationship between soluble interleukin-2 receptor levels and antidouble stranded DNA antibody levels in patients with systemic lupus erythematosus.J Rheumatol, 1991; 18: 235 - 240

共引文献24

同被引文献90

引证文献2

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部